Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancer. (Record no. 8547046)

MARC details
000 -LEADER
fixed length control field 01511 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513083949.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199602s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1062-8401
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1089/cbr.1995.10.225
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Sella, A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19960221
245 00 - TITLE STATEMENT
Title Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer biotherapy
Date of publication, distribution, etc. 1995
300 ## - PHYSICAL DESCRIPTION
Extent 225-35 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibiotics, Antineoplastic
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dactinomycin
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme-Linked Immunosorbent Assay
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infusions, Intravenous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prostatic Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Tumor Necrosis Factor
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Cells, Cultured
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Necrosis Factor-alpha
General subdivision metabolism
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Aggarwal, B B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kilbourn, R G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bui, C A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zukiwski, A A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Logothetis, C J
773 0# - HOST ITEM ENTRY
Title Cancer biotherapy
Related parts vol. 10
-- no. 3
-- p. 225-35
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1089/cbr.1995.10.225">https://doi.org/10.1089/cbr.1995.10.225</a>
Public note Available from publisher's website

No items available.